Atlas Trials

The Benefit of Hemodialysis Plus Hemoperfusion on Mortality

Clinical trial NCT03227770 · COMPLETED

Trial details

NCT number
NCT03227770
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
End-stage Renal Disease
Start date
2017-12-01
Primary completion
2021-12-31
Enrollment
1362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.